Logo image of CSL

CARLISLE COS INC (CSL) Stock Fundamental Analysis

NYSE:CSL - New York Stock Exchange, Inc. - US1423391002 - Common Stock - Currency: USD

354.71  -55.86 (-13.61%)

After market: 380 +25.29 (+7.13%)

Fundamental Rating

7

Overall CSL gets a fundamental rating of 7 out of 10. We evaluated CSL against 41 industry peers in the Building Products industry. Both the health and profitability get an excellent rating, making CSL a very profitable company, without any liquidiy or solvency issues. CSL has a decent growth rate and is not valued too expensively. These ratings could make CSL a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CSL was profitable.
CSL had a positive operating cash flow in the past year.
CSL had positive earnings in each of the past 5 years.
Each year in the past 5 years CSL had a positive operating cash flow.
CSL Yearly Net Income VS EBIT VS OCF VS FCFCSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CSL's Return On Assets of 23.13% is amongst the best of the industry. CSL outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 58.19%, CSL belongs to the best of the industry, outperforming 95.12% of the companies in the same industry.
CSL has a Return On Invested Capital of 17.59%. This is amongst the best in the industry. CSL outperforms 85.37% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSL is above the industry average of 12.82%.
The last Return On Invested Capital (17.59%) for CSL is above the 3 year average (15.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 23.13%
ROE 58.19%
ROIC 17.59%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
CSL Yearly ROA, ROE, ROICCSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CSL's Profit Margin of 25.20% is amongst the best of the industry. CSL outperforms 100.00% of its industry peers.
CSL's Profit Margin has improved in the last couple of years.
CSL's Operating Margin of 22.02% is amongst the best of the industry. CSL outperforms 92.68% of its industry peers.
CSL's Operating Margin has improved in the last couple of years.
CSL has a Gross Margin of 37.47%. This is in the better half of the industry: CSL outperforms 63.41% of its industry peers.
In the last couple of years the Gross Margin of CSL has grown nicely.
Industry RankSector Rank
OM 22.02%
PM (TTM) 25.2%
GM 37.47%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
CSL Yearly Profit, Operating, Gross MarginsCSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CSL is creating some value.
CSL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CSL has been reduced compared to 5 years ago.
The debt/assets ratio for CSL has been reduced compared to a year ago.
CSL Yearly Shares OutstandingCSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSL Yearly Total Debt VS Total AssetsCSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 6.80 indicates that CSL is not in any danger for bankruptcy at the moment.
CSL has a better Altman-Z score (6.80) than 75.61% of its industry peers.
CSL has a debt to FCF ratio of 2.49. This is a good value and a sign of high solvency as CSL would need 2.49 years to pay back of all of its debts.
CSL's Debt to FCF ratio of 2.49 is fine compared to the rest of the industry. CSL outperforms 73.17% of its industry peers.
CSL has a Debt/Equity ratio of 0.87. This is a neutral value indicating CSL is somewhat dependend on debt financing.
The Debt to Equity ratio of CSL (0.87) is worse than 73.17% of its industry peers.
Although CSL does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 2.49
Altman-Z 6.8
ROIC/WACC1.77
WACC9.96%
CSL Yearly LT Debt VS Equity VS FCFCSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CSL has a Current Ratio of 2.58. This indicates that CSL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.58, CSL is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that CSL should not have too much problems paying its short term obligations.
CSL's Quick ratio of 1.69 is fine compared to the rest of the industry. CSL outperforms 75.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.69
CSL Yearly Current Assets VS Current LiabilitesCSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

CSL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.02%.
CSL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.74% yearly.
Looking at the last year, CSL shows a quite strong growth in Revenue. The Revenue has grown by 9.08% in the last year.
Measured over the past years, CSL shows a small growth in Revenue. The Revenue has been growing by 0.79% on average per year.
EPS 1Y (TTM)7.02%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%0.48%
Revenue 1Y (TTM)9.08%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.08%

3.2 Future

Based on estimates for the next years, CSL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.19% on average per year.
The Revenue is expected to grow by 4.74% on average over the next years.
EPS Next Y10.63%
EPS Next 2Y12.09%
EPS Next 3Y12.19%
EPS Next 5YN/A
Revenue Next Year3.36%
Revenue Next 2Y4.27%
Revenue Next 3Y4.74%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSL Yearly Revenue VS EstimatesCSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CSL Yearly EPS VS EstimatesCSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.62, which indicates a rather expensive current valuation of CSL.
Compared to the rest of the industry, the Price/Earnings ratio of CSL is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.25. CSL is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 13.97, the valuation of CSL can be described as correct.
Based on the Price/Forward Earnings ratio, CSL is valued a bit cheaper than 63.41% of the companies in the same industry.
CSL is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.62
Fwd PE 13.97
CSL Price Earnings VS Forward Price EarningsCSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CSL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CSL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 20.22
EV/EBITDA 15.14
CSL Per share dataCSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CSL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CSL has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CSL's earnings are expected to grow with 12.19% in the coming years.
PEG (NY)1.66
PEG (5Y)0.89
EPS Next 2Y12.09%
EPS Next 3Y12.19%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.94%, CSL is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.12, CSL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CSL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

On average, the dividend of CSL grows each year by 15.64%, which is quite nice.
CSL has been paying a dividend for at least 10 years, so it has a reliable track record.
CSL has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.64%
Div Incr Years34
Div Non Decr Years34
CSL Yearly Dividends per shareCSL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

CSL pays out 13.97% of its income as dividend. This is a sustainable payout ratio.
CSL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP13.97%
EPS Next 2Y12.09%
EPS Next 3Y12.19%
CSL Yearly Income VS Free CF VS DividendCSL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CSL Dividend Payout.CSL Dividend Payout, showing the Payout Ratio.CSL Dividend Payout.PayoutRetained Earnings

CARLISLE COS INC

NYSE:CSL (7/31/2025, 7:06:47 PM)

After market: 380 +25.29 (+7.13%)

354.71

-55.86 (-13.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners98.33%
Inst Owner Change-0.08%
Ins Owners0.74%
Ins Owner Change6.9%
Market Cap15.34B
Analysts78.46
Price Target457.18 (28.89%)
Short Float %6.67%
Short Ratio6.78
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly Dividend3.74
Dividend Growth(5Y)15.64%
DP13.97%
Div Incr Years34
Div Non Decr Years34
Ex-Date05-19 2025-05-19 (1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.39%
Min EPS beat(2)0.14%
Max EPS beat(2)4.64%
EPS beat(4)3
Avg EPS beat(4)1.67%
Min EPS beat(4)-1.66%
Max EPS beat(4)4.64%
EPS beat(8)7
Avg EPS beat(8)8.31%
EPS beat(12)10
Avg EPS beat(12)7.7%
EPS beat(16)14
Avg EPS beat(16)10.63%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)-0.38%
Revenue beat(8)2
Avg Revenue beat(8)-0.33%
Revenue beat(12)3
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)1.29%
PT rev (1m)2.64%
PT rev (3m)1.48%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-4.2%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-1.44%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 17.62
Fwd PE 13.97
P/S 3.07
P/FCF 20.22
P/OCF 17.66
P/B 7.08
P/tB N/A
EV/EBITDA 15.14
EPS(TTM)20.13
EY5.68%
EPS(NY)25.39
Fwd EY7.16%
FCF(TTM)17.54
FCFY4.95%
OCF(TTM)20.08
OCFY5.66%
SpS115.67
BVpS50.09
TBVpS-18.95
PEG (NY)1.66
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 23.13%
ROE 58.19%
ROCE 22.67%
ROIC 17.59%
ROICexc 18.42%
ROICexgc 51.74%
OM 22.02%
PM (TTM) 25.2%
GM 37.47%
FCFM 15.17%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
ROICexc(3y)17.52%
ROICexc(5y)13.93%
ROICexgc(3y)50.21%
ROICexgc(5y)41.16%
ROCE(3y)20.13%
ROCE(5y)15.97%
ROICexcg growth 3Y28.32%
ROICexcg growth 5Y11.4%
ROICexc growth 3Y36.27%
ROICexc growth 5Y11.03%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 2.49
Debt/EBITDA 1.47
Cap/Depr 60.5%
Cap/Sales 2.19%
Interest Coverage 250
Cash Conversion 67.7%
Profit Quality 60.19%
Current Ratio 2.58
Quick Ratio 1.69
Altman-Z 6.8
F-Score6
WACC9.96%
ROIC/WACC1.77
Cap/Depr(3y)69.38%
Cap/Depr(5y)62.06%
Cap/Sales(3y)2.91%
Cap/Sales(5y)2.9%
Profit Quality(3y)99.02%
Profit Quality(5y)110.75%
High Growth Momentum
Growth
EPS 1Y (TTM)7.02%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%0.48%
EPS Next Y10.63%
EPS Next 2Y12.09%
EPS Next 3Y12.19%
EPS Next 5YN/A
Revenue 1Y (TTM)9.08%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.08%
Revenue Next Year3.36%
Revenue Next 2Y4.27%
Revenue Next 3Y4.74%
Revenue Next 5YN/A
EBIT growth 1Y-8.82%
EBIT growth 3Y24.59%
EBIT growth 5Y11.81%
EBIT Next Year22.68%
EBIT Next 3Y12.39%
EBIT Next 5YN/A
FCF growth 1Y-16.94%
FCF growth 3Y47.3%
FCF growth 5Y8.35%
OCF growth 1Y-21.48%
OCF growth 3Y34.69%
OCF growth 5Y7.94%